Market Cap

Destiny Pharma plc Market Capitalization:

£8.1 Million

GBP as of July 1, 2024

US$10.3 Million

business Destiny Pharma plc Company Profile

Destiny Pharma plc Main Stock Listing

LSE: DEST

Market Capitalization History of Destiny Pharma plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Destiny Pharma plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £66.7 M 64.77%
Jan. 1, 2023 £40.5 M -35.84%
Jan. 1, 2022 £63.1 M -25.11%
Jan. 1, 2021 £84.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Destiny Pharma plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Destiny Pharma plc has the following listings and related stock indices.


Stock: LSE: DEST

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.